Skip to main content

News & Events

News & Announcements

For Biotech Companies, Guarding Concepts is Critical

Baltimore Sun, Black Enterprise,

If Alba Therapeutics Corp. didn’t have product protection for the 200 patents it has either applied for or been issued, the Baltimore biotech might be $300 million poorer, according to news reports. Speaking from his office at the new UMBioPark, Blake Paterson, MD, Alba’s chief executive officer and co-founder, said, “If you're making that sort of investment, and taking that degree of risk, you need to have a patent on that product. ... It’s fundamental.”